Royalty Pharma (RPRX)
(Delayed Data from NSDQ)
$26.77 USD
+0.04 (0.15%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $26.76 -0.01 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $0.93 | 1.08% |
Earnings Summary
For their last quarter, Royalty Pharma (RPRX) reported earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.96 per share. This reflects a positive earnings surprise of 2.08%. Look out for RPRX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of $0.93 per share, reflecting a year-over-year increase of 9.41%.
Earnings History
Price & Consensus
Zacks News for RPRX
Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study
RPRX: What are Zacks experts saying now?
Zacks Private Portfolio Services